Aster DM Healthcare Limited published newspaper clippings regarding its audited financial results for the quarter and year ended March 31, 2026, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Newspaper Publication and Regulatory Compliance

The company published the financial results newspaper clippings on May 01, 2026, as confirmed by Company Secretary and Compliance Officer Hemish Purushottam through official communication to stock exchanges. The publication includes Quick Response Code (QR Code) and weblink access to complete financial results for the specified period.

Board Meeting Outcome

The Board of Directors successfully concluded its meeting on April 30, 2026, approving the audited standalone and consolidated financial results for fiscal year 2026. The meeting, conducted under Regulation 29 of SEBI regulations, commenced at 10:30 AM IST and concluded at 03:35 PM IST.

Auditor's Report and Opinion

Deloitte Haskins & Sells, the company's statutory auditors, issued their auditors' report with an unmodified opinion on both standalone and consolidated financial results. The audit was conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013, with Partner Ankit Daga (Membership No. 512486) signing the report on April 30, 2026.

Corporate Office Information

The company maintains its registered office at No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Hyderabad, Ameerpet, Telangana, India - 500038, with corporate office located at Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Sampangi Rama Nagar, Bengaluru, Karnataka, India - 560027.

Aster DM Healthcare has successfully completed its strategic acquisition in the renewable energy sector, purchasing a 26% stake in Oyster Green Hybrid Two Private Limited for a revised consideration of ₹5.80 crore. The healthcare major announced the completion of this acquisition on April 23, 2026, marking a significant milestone in its renewable energy initiative.

Acquisition Completion Details

The company has completed the acquisition through a two-tranche payment structure, with the final tranche completed on April 22, 2026. The investment details are outlined below:

The total consideration was revised from the originally agreed ₹7.00 crore to ₹5.80 crore pursuant to a reduction in the overall project cost. The Group, comprising Aster DM Healthcare and its material subsidiary Malabar Institute of Medical Sciences Limited (MIMS), has completed the acquisition of 26% of the equity share capital of Oyster Green Hybrid Two.

Project Specifications

The acquisition enables Aster DM Healthcare to establish an 18 MWp captive solar power plant in Kerala. Oyster Green Hybrid Two will build, develop, install, commission, operate, manage, and maintain the solar power facility. The company and its material subsidiary MIMS will purchase 100% of the net output electricity generated from this captive solar power plant.

Target Company Profile

Oyster Green Hybrid Two Private Limited was incorporated on January 22, 2024, and is engaged in building, developing, installing, commissioning, operating, and maintaining solar power plants across India. The company's financial position shows:

Strategic Impact

This acquisition represents Aster DM Healthcare's commitment to sustainable energy solutions and operational cost optimization. The 26% stake acquisition complies with statutory requirements under the Electricity Act, which mandates that captive users hold not less than 26% ownership in such projects. The captive solar power plant will provide dedicated clean energy capacity, supporting the company's environmental sustainability goals while ensuring energy security for its healthcare facilities in Kerala.